copGFP Control Plasmid from Santa Cruz Biotechnology, Inc.

Product Specs
ItemcopGFP Control Plasmid
CompanySanta Cruz Biotechnology, Inc.
Price $90.00Supplier Page View Company Product Page
Catalog Numbersc-108083
Domain/Region/TerminusVector Search
Quantity20 µg
Selectable Markerpuromycin
Vector NamecopGFP Control Plasmid
TypePlasmid

Specifications/Features

Features:

20 ug, up to 20 transfections
copGFP Plasmid is a lentiviral vector plasmid that encodes the copGFP fluorescent protein
provided as transfection-ready purified plasmid DNA
after transfection, cells stably expressing copGFP may be isolated via puromycin selection
copGFP Control Plasmid is intended only for non-commercial use.

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancerMolecular OncologyMarch 1, 2024Adi Alfandari, Dotan Moskovich, Avivit Weisz, Aviva Katzav, Debora Kidron, Mario Beiner, Dana Josephy, Aula Asali, Yael Hants, Yael Yagur, et al.plasmid transfection reagent (sc‐108061, Santa Cruz Technologies). GFP plasmid was used as a positive control (sc‐108083, Santa Cruz Technologies), and nonspecific mock shRNA plasmid (scrambled) was used as negative control

(2) MicroRNA-18a-5p represses scar fibroblast proliferation and extracellular matrix deposition through regulating Smad2 expressionExperimental and therapeutic medicineNovember 1, 2021Li T, Wu Y, Liu D, Zhuang L.Smad2-plasmid (cat. no. sc-421525-ACT; Santa Cruz Biotechnology, Inc.), 1 µg control-plasmid (cat. no. sc-108083; Santa Cruz Biotechnology, Inc.) or 100 nM miR-18a-5p mimic + 1 µg Smad2-plasmid using Lipofectamine®

(3) Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLECellAugust 19, 2021Caielli S, Cardenas J, de Jesus AA, Baisch J, Walters L, Blanck JP, Balasubramanian P, Stagnar C, Ohouo M, Hong S, et al.

(4) The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and diseaseCardiovascular researchMay 25, 2021Mahmoud M, Mayer M, Cancel LM, Bartosch AM, Mathews R, Tarbell JM.

(5) Regulation of Circular RNA CircNFATC3 in Cancer Cells Alters Proliferation, Migration, and Oxidative PhosphorylationFrontiers in cell and developmental biologyJanuary 1, 2021Karedath T, Al-Dasim FM, Ahmed I, Al-Qurashi A, Raza A, Andrews SS, Ahmed AA, Ali Mohamoud Y, Dermime S, Malek JA.Cell Proliferation Assay was conducted. Collagen Invasion Assay in 3D Model copGFP Control Plasmid:sc-108083 (Santa Cruz Biotechnology) was used to express GFP in the cells. After 48 h of transfection, puromycin

(6) Does survivin overexpression enhance the efficiency of fibroblast cell-based wound therapy?Molecular biology reportsAugust 1, 2020Shojaei-Ghahrizjani F, Rahmati S, Mirzaei SA, Banitalebi-Dehkordi M.

(7) Abnormal expression of miR-135b-5p in bone tissue of patients with osteoporosis and its role and mechanism in osteoporosis progressionExperimental and therapeutic medicineFebruary 1, 2020Chen B, Yang W, Zhao H, Liu K, Deng A, Zhang G, Pan K.(RUNX2)‑plasmid (cat. no. sc‑400183‑ACT; Santa Cruz Biotechnology, Inc.), 2 µl control‑plasmid (cat. no. sc‑108083; Santa Cruz Biotechnology, Inc.) or 100 nM miR‑135b‑5p mimic + 2 µl RUNX2‑plasmid were transfected into

(8) MicroRNA-135a-5p is involved in osteoporosis progression through regulation of osteogenic differentiation by targeting RUNX2Experimental and therapeutic medicineOctober 1, 2019Shi X, Zhang Z.(5′-UCACAUAGGAAUAAAAAGCCAUA-3′), 100 nM inhibitor control (5′-CAGUACUUUUGUGUAGUACAA-3′), 2 µl control-plasmid (cat. no. sc-108083), 2 µl RUNX2-plasmid (cat. no. sc-400183-ACT; both Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA),

(9) MicroRNA‑140 suppresses Helicobacter pylori‑positive gastric cancer growth by enhancing the antitumor immune responseMolecular medicine reportsSeptember 1, 2019Zhao M, Liu Q, Liu W, Zhou H, Zang X, Lu J.Then 100 nM miR‑140 mimic, 100 nM mimic control, 100 nM miR‑140 mimic + 1 µg control‑plasmid (cat. no. sc‑108083; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), or 100 nM miR‑140 mimic + 1 µg PD‑L1‑plasmid (cat.

(10) MicroRNA-15b participates in the development of peripheral arterial disease by modulating the growth of vascular smooth muscle cellsExperimental and therapeutic medicineJuly 1, 2019Sun Y, Gao Y, Song T, Yu C, Nie Z, Wang X.(5′-CAGUACUUUUGUGUAGUACAA-3′; all Shanghai GenePharma Co., Ltd., Shanghai, China), 2 µl control-plasmids (cat. no. sc-108083), 2 µl insulin growth factor 1 receptor (IGF1R)-plasmids (cat. no. sc-421057-ACT; both Santa Cruz Biotechnology, Inc

(11) MicroRNA‑486‑5p inhibits the growth of human hypertrophic scar fibroblasts by regulating Smad2 expressionMolecular medicine reportsJune 1, 2019Shi Y, Wang L, Yu P, Liu Y, Chen W.obtained from Guangzhou RiboBio Co., Ltd. (Guangzhou, China). control-plasmid (control-p; cat. no. sc-108083) and Smad2-plasmid (plasmid; cat. no. sc-421525-ACT) were purchased from Santa Cruz Biotechnology, Inc.

(12) p53-Mediated Activities in NS-5 Neural Stem Cells: Effects of EthanolAlcoholism, clinical and experimental researchApril 1, 2019Miller MW.

(13) MicroRNA‑31 promotes chondrocyte proliferation by targeting C‑X‑C motif chemokine ligand 12Molecular medicine reportsMarch 1, 2019Dai Y, Liu S, Xie X, Ding M, Zhou Q, Zhou X.(forward: 5′UUCUCCGAACGUGUCACGUTT3′, reverse: 5′ACGUGACACGUUCGGAGAATT3′), 2 µl control plasmid (cat. no. sc-108083; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), 2 µl CXCL12-plasmid (cat. no. sc-422854-ACT;

(14) SOX2 Activation Using CRISPR/dCas9 Promotes Wound Healing in Corneal Endothelial CellsStem CellsDecember 1, 2018Chang YK, Hwang JS, Chung TY, Shin YJ.

(15) DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cellsCellular & molecular biology lettersJanuary 1, 2018Nikitakis NG, Gkouveris I, Aseervatham J, Barahona K, Ogbureke KUE.

(16) NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathwayPloS oneJanuary 1, 2018Tang Y, Blomenkamp KS, Fickert P, Trauner M, Teckman JH.cat# sc-41445), control shRNA plasmid-A (1 μg, cat# sc-108060), and copGFP control plasmid (1 μg, cat# sc-108083), respectively, in Opt-MEM (125 μl). Add diluted DNA to each tube of Lipofectamine® 3000 Reagent (1:1

(17) shRNA-mediated downregulation of α-N-Acetylgalactosaminidase inhibits migration and invasion of cancer cell linesIranian journal of basic medical sciencesSeptember 1, 2017Saburi E, Tavakolafshari J, Mortazavi Y, Biglari A, Mirzaei SA, Nadri S.

(18) Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathwayScientific reportsJune 9, 2017Taverna S, Pucci M, Giallombardo M, Di Bella MA, Santarpia M, Reclusa P, Gil-Bazo I, Rolfo C, Alessandro R.

(19) Flowtaxis of osteoblast migration under fluid shear and the effect of RhoA kinase silencingPloS oneJanuary 1, 2017Riehl BD, Lee JS, Ha L, Kwon IK, Lim JY.control using the green fluorescent protein (GFP)-tagged control plasmid (Santa Cruz Biotechnology, sc-108083). All the cell migration tests were completed with using the vector control cells unless noted as ROCK-shRNA

(20) Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathyBMC nephrologyNovember 17, 2016Fujino T, Hasebe N.

Be the First to Write a Review!